What is the initial dose of 70/30 insulin and when to review for a 92.2kg patient with severe hyperglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Insulin Dosing for Severe Hyperglycemia in a 92.2kg Patient

For a 92.2kg patient with severe hyperglycemia, initiate 70/30 insulin at 18-28 units twice daily (0.2-0.3 units/kg/day), with review within 3 days. A stat dose of 10 units of soluble insulin can be given initially to rapidly address severe hyperglycemia.

Initial Insulin Dosing Calculation

The appropriate initial insulin dosing for this patient should be based on weight and severity of hyperglycemia:

  • For patients with severe hyperglycemia, insulin is typically started at 0.2-0.3 units/kg/day 1
  • For a 92.2kg patient:
    • Low-end dose: 92.2kg × 0.2 units/kg/day = 18.4 units/day
    • High-end dose: 92.2kg × 0.3 units/kg/day = 27.7 units/day

70/30 Insulin Administration

  • 70/30 insulin contains 70% NPH (intermediate-acting) and 30% regular insulin (short-acting)
  • This premixed insulin should be administered twice daily, typically before breakfast and dinner
  • Initial dosing recommendation: 18-28 units twice daily, divided equally between morning and evening doses

Stat Dose of Soluble Insulin

A stat dose of 10 units of soluble (regular) insulin is appropriate in this scenario:

  • For patients with marked hyperglycemia, immediate correction with soluble insulin helps rapidly reduce blood glucose levels 1
  • The 10-unit stat dose will help address acute hyperglycemia while the 70/30 insulin regimen is being established
  • This approach aligns with guidelines for managing severe hyperglycemia at presentation 1

Follow-up and Monitoring

  • Review the patient within 3 days to assess response to therapy 1
  • During follow-up:
    • Evaluate fasting and postprandial glucose readings
    • Adjust insulin dose based on blood glucose patterns
    • Consider increasing dose by 10-30% if glycemic targets are not met 1

Titration Algorithm

Adjust the 70/30 insulin dose based on blood glucose readings:

  • If fasting glucose ≥180 mg/dL: Increase by 6-8 units
  • If fasting glucose 140-179 mg/dL: Increase by 4 units
  • If fasting glucose 120-139 mg/dL: Increase by 2 units
  • If fasting glucose 100-119 mg/dL: Maintain or increase by 0-2 units
  • If fasting glucose <100 mg/dL: Decrease by 2-4 units
  • Any hypoglycemia (<70 mg/dL): Decrease by 10-20% 2

Important Considerations

  • Ensure frequent blood glucose monitoring (at least 4 times daily) during initial therapy
  • Educate the patient on hypoglycemia recognition and management
  • If glycemic targets are not achieved with 70/30 insulin despite dose optimization, consider transitioning to a basal-bolus regimen 1
  • For patients with persistent hyperglycemia despite basal insulin doses exceeding 0.5 units/kg/day, consider adding prandial insulin coverage 1

This approach provides immediate management of severe hyperglycemia while establishing a sustainable insulin regimen that can be adjusted based on the patient's response.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.